Volume 10,Issue 4
Standardized Management of Intravenous Infusion of High-risk Drugs in the Emergency Department
Objective: To collect the nursing staff who manage high-risk intravenous infusion drugs in the emergency department of our hospital from 2023.7 to 2025.7. Methods: The total sample size is 32 cases. They will implement routine management before July 2024 and define them as the control group; those who will implement standardized management after July 2024 will be defined as the observation group. Evaluate the implementation of management processes between groups, management effectiveness indicators, management quality scores and medical staff satisfaction scores. Results: The observation group had higher management process execution scores than the control group, P<0.05. The response time for problem rectification in the observation group was shorter than that in the control group, and the number of monthly quality analysis reports, process optimization suggestions, and cross-department collaboration scores in the observation group were higher than those in the control group, P<0.05. The management quality score of the observation group was higher than that of the control group, P<0.05. The satisfaction score of medical staff in the observation group was higher than that in the control group, P<0.05. Conclusion: The implementation of standardized management in the management of high-risk intravenous infusion drugs in emergency departments is of significant value in promoting the implementation of management processes, improving management efficiency and quality, and improving the satisfaction of medical staff.
[1] Yan X, Yu KY, He C, 2025, Application of Nursing Management Model Based on Swiss Cheese Model in Safe Medication Use in Emergency Departments. China Health Industry, 22(19): 139-141+150.
[2] Jin CJ, Wang YT, 2025, Discussion on Risk Management and Medical Quality Management of Traditional Chinese Medicine Injection in the Emergency Department of a Hospital. Journal of Traditional Chinese Medicine Management, 33(16): 192-194.
[3] Wu R, Yu DF, 2025, Practice of Special Risk Management to Improve the Rational Use of Chinese Patent Medicines in Emergency Departments. Journal of Traditional Chinese Medicine Management, 33(15): 49-51.
[4] Yan X, Yu KY, He C, 2025, Application of Risk Prevention Management Under the Guidance of Hain’s Law in Emergency Department Nursing Management. China Health Industry, 22(13): 189-191+196.
[5] Xu C, Chen B, Chen W, et al., 2025, Evaluation of the Effectiveness of Emergency Intravenous Glucocorticoid Management Based on Rational Drug Use System Prescription Review. Chinese Prescription Drugs, 23(12): 41-45.
[6] Wei CH, Li LZ, 2025, Observation on the Effect of Applying Drug Therapy Management Model in Intravenous Antimicrobial Drug Management in Emergency Departments. Chinese Journal of Drug Abuse Prevention and Control, 31(6): 1044-1046.
[7] Zhou L, 2021, Observation on the Effect of Safety Management on the Application of High-Risk Drugs in General Emergency Departments. Journal of Traditional Chinese Medicine Management, 29(13): 201-203.
[8] Xu T, Wang YJ, Zhang JP, et al., 2025, Application of Integrated Medical and Nursing Management in the Safe Use of Chinese Patent Medicines in Emergency Departments. Journal of Traditional Chinese Medicine Management, 33(7): 131-133.
[9] Chen Q, Feng MP, 2023, Application of Standardized Management Based on JCI System in the Management of High-Risk Drugs in Neurology. Journal of Traditional Chinese Medicine Management, 31(5): 116-118.
[10] Han CY, 2022, Analysis of Influencing Factors on Emergency Department Nurses’ Cognition of Intravenous Infusion of High-Risk Drugs. Chinese and Foreign Medical, 41(15): 124-128+133.